Raras
Buscar doenças, sintomas, genes...
Síndrome da pele rígida
ORPHA:2833CID-10 · L98.8CID-11 · EE6YOMIM 184900DOENÇA RARA

Uma síndrome rara caracterizada por pele dura e espessa, geralmente em todo o corpo. O espessamento da pele pode limitar o movimento das articulações e fazer com que elas fiquem presas em uma posição dobrada (chamadas contraturas em flexão). Os sinais e sintomas podem aparecer desde o nascimento até a infância. Outros sinais e sintomas podem incluir crescimento excessivo de pelos (hipertricose), perda de gordura corporal (lipodistrofia), escoliose, fraqueza muscular, crescimento lento e baixa estatura. Fraqueza ou paralisia dos músculos dos olhos também foram relatadas. A síndrome da pele rígida é causada por mutações (alterações) no gene FBN1 e é herdada de forma autossômica dominante. O diagnóstico é feito com base em uma avaliação clínica compatível com a síndrome da pele rígida, e pode ser confirmado com testes genéticos. O tratamento é baseado nos sintomas de cada pessoa e pode incluir fisioterapia.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Uma síndrome rara caracterizada por pele dura e espessa, geralmente em todo o corpo. O espessamento da pele pode limitar o movimento das articulações e fazer com que elas fiquem presas em uma posição dobrada (chamadas contraturas em flexão). Os sinais e sintomas podem aparecer desde o nascimento até a infância. Outros sinais e sintomas podem incluir crescimento excessivo de pelos (hipertricose), perda de gordura corporal (lipodistrofia), escoliose, fraqueza muscular, crescimento lento e baixa estatura. Fraqueza ou paralisia dos músculos dos olhos também foram relatadas. A síndrome da pele rígida é causada por mutações (alterações) no gene FBN1 e é herdada de forma autossômica dominante. O diagnóstico é feito com base em uma avaliação clínica compatível com a síndrome da pele rígida, e pode ser confirmado com testes genéticos. O tratamento é baseado nos sintomas de cada pessoa e pode incluir fisioterapia.

Publicações científicas
82 artigos
Último publicado: 2025 Nov-Dec

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
54
pacientes catalogados
Início
Childhood
+ infancy, neonatal
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: L98.8
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧬
Pele e cabelo
7 sintomas
💪
Músculos
6 sintomas
👁️
Olhos
5 sintomas
🦴
Ossos e articulações
3 sintomas
😀
Face
3 sintomas
📏
Crescimento
2 sintomas

+ 7 sintomas em outras categorias

Características mais comuns

100%prev.
Camptodactilia
Frequência: 8/8
100%prev.
Pele rígida
Frequência: 8/8
100%prev.
Contratura em flexão do cotovelo
Frequência: 8/8
100%prev.
HP:0003577
Frequência: 8/8
90%prev.
Limitação da mobilidade articular
Muito frequente (99-80%)
90%prev.
Pele espessada
Muito frequente (99-80%)
40sintomas
Muito frequente (9)
Frequente (4)
Ocasional (21)
Muito raro (1)
Sem dados (5)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 40 características clínicas mais associadas, ordenadas por frequência.

CamptodactiliaCamptodactyly
Frequência: 8/8100%
Pele rígidaStiff skin
Frequência: 8/8100%
Contratura em flexão do cotoveloElbow flexion contracture
Frequência: 8/8100%
HP:0003577
Frequência: 8/8100%
Limitação da mobilidade articularLimitation of joint mobility
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico82PubMed
Últimos 10 anos41publicações
Pico20206 papers
Linha do tempo
2026Hoje · 2026📈 2020Ano de pico🧪 2022Primeiro ensaio clínico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal dominant.

FBN1Fibrillin-1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Structural component of the 10-12 nm diameter microfibrils of the extracellular matrix, which conveys both structural and regulatory properties to load-bearing connective tissues (PubMed:15062093, PubMed:1860873). Fibrillin-1-containing microfibrils provide long-term force bearing structural support (PubMed:27026396). In tissues such as the lung, blood vessels and skin, microfibrils form the periphery of the elastic fiber, acting as a scaffold for the deposition of elastin (PubMed:27026396). In

LOCALIZAÇÃO

SecretedSecreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (2)
Post-translational protein phosphorylationRegulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
MECANISMO DE DOENÇA

Marfan syndrome

A hereditary disorder of connective tissue that affects the skeletal, ocular, and cardiovascular systems. A wide variety of skeletal abnormalities occurs with Marfan syndrome, including scoliosis, chest wall deformity, tall stature, abnormal joint mobility. Ectopia lentis occurs in most of the patients and is almost always bilateral. The leading cause of premature death is progressive dilation of the aortic root and ascending aorta, causing aortic incompetence and dissection. Neonatal Marfan syndrome is the most severe form resulting in death from cardiorespiratory failure in the first few years of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
295.9 TPM
Artéria coronária
63.8 TPM
Aorta
63.1 TPM
Tecido adiposo
54.3 TPM
Esôfago - Junção
48.0 TPM
OUTRAS DOENÇAS (14)
geleophysic dysplasia 2Weill-Marchesani syndrome 2, dominantMASS syndromeectopia lentis 1, isolated, autosomal dominant
HGNC:3603UniProt:P35555

Variantes genéticas (ClinVar)

4,741 variantes patogênicas registradas no ClinVar.

🧬 FBN1: NM_000138.5(FBN1):c.4210+1G>C ()
🧬 FBN1: NM_000138.5(FBN1):c.1147+5G>A ()
🧬 FBN1: NM_000138.5(FBN1):c.6629_6639del (p.Cys2210fs) ()
🧬 FBN1: NM_000138.5(FBN1):c.7828G>T (p.Glu2610Ter) ()
🧬 FBN1: NM_000138.5(FBN1):c.3713A>C (p.Asp1238Ala) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 508 variantes classificadas pelo ClinVar.

203
305
Patogênica (40.0%)
VUS (60.0%)
VARIANTES MAIS SIGNIFICATIVAS
FBN1: NM_000138.5(FBN1):c.5336dup (p.Asn1779fs) [Pathogenic]
FBN1: NM_000138.5(FBN1):c.5006_5013del (p.Asn1669fs) [Likely pathogenic]
FBN1: NM_000138.5(FBN1):c.7867C>G (p.His2623Asp) [Conflicting classifications of pathogenicity]
FBN1: NM_000138.5(FBN1):c.407G>T (p.Cys136Phe) [Pathogenic/Likely pathogenic]
FBN1: NM_000138.5(FBN1):c.6569G>A (p.Cys2190Tyr) [Likely pathogenic]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
1Fase 11
·Pré-clínico2
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 3 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome da pele rígida

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

2 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

0 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
40 papers (10 anos)
#1

Clinicopathological Challenge: A Progressively Enlarging Hardened Skin Plaque.

International journal of dermatology2026 Jan

Stiff skin syndrome (SSS) is a rare connective tissue disease manifesting as a progressive, non-inflammatory fibrosis that causes the skin and soft tissues to harden. It can result in restricted joint movement, particularly affecting the shoulder and pelvic girdle. A segmental variant with a better prognosis has been described. Due to its similarity in presentation to other scleroderma-like conditions, this case report will discuss it as a diagnostic challenge.

#2

The clinical phenotypes and therapeutic strategies for stiff skin syndrome: a case series with literature review.

Orphanet journal of rare diseases2025 Jun 23

Stiff skin syndrome (SSS) is a rare, non-inflammatory skin disease with a pronounced restriction in joint mobility. In this study, we aim to report Chinese pediatric patients with SSS in our center and summarize the clinical features of the disease through literature review. A retrospective study was conducted on 16 pediatric patients diagnosed with SSS at Peking Union Medical College Hospital between January 2014 and January 2024, based on clinical manifestations, laboratory tests, and skin biopsy findings. Among these cases, two were classified as widespread SSS, and 14 as segmental SSS. Additionally, a review of relevant literature published between January 2000 and January 2024 involving 138 cases of pediatric SSS was also conducted. The clinical characteristics, treatment, and prognosis of these 154 patients were summarized. The age of onset in patients was 2.0(0.5, 4.8) years, with an average age at diagnosis being 9.0(5.0, 13.0) years. Thigh skin sclerosis (81, 52.6%) was the most common manifestation observed in these patients. Joint restriction was present in 55(35.7%) patients. Patients with joint contractures had longer diagnostic delays compared with those without joint contractures. Patients were primarily treated with physical therapy, while some patients received medications such as mycophenolate mofetil (MMF), losartan, and secukinumab. However, the prognosis varied. The diagnosis of SSS should involve a thorough investigation of family history, detailed physical examination, comprehensive pathological assessment, genetic testing when applicable, and careful exclusion of other scleroderma-like diseases. Currently, there is limited evidence supporting the use of systemic treatment options targeting the transforming growth factor-β or interleukin-17 pathways (such as MMF, losartan, and secukinumab) to slow disease progression. However, these treatments are not capable of reversing established skin lesions, and further investigations are imperative to assess their therapeutic efficacy in SSS.

#3

Reflections on The Thing's rocklike skin.

Clinics in dermatology2025

The Thing is a Marvel Comics superhero who sports rocklike skin. This contribution describes The Thing's cutaneous features and explores similar rocky exteriors in the Stone Giants and other stony creatures described in legends, folklore, and fiction. In the real world, some animals resemble rocks and stones, such as the rock hyrax, stone fish, Pyura chilensis, and common toad. There are also children suffering from stiff skin syndrome, a rare genetic disorder that causes their skin to become stony-hard. The clinical features of this syndrome are highlighted in this contribution.

#4

[Case of stiff skin syndrome treated with acupuncture and cupping therapy].

Zhongguo zhen jiu = Chinese acupuncture &amp; moxibustion2025 Jul 12

Stiff skin syndrome is a very rare non-inflammatory reactive skin disease, characterized by skin sclerosis and limited joint mobility. The paper reports one case of child with stiff skin syndrome and treated with combined therapy of acupuncture and cupping. Acupuncture was used at the lateral line 1 of vertex (MS8) on the right side, Jiaji (EX-B2) of L2 to L4, Huantiao (GB30), ashi point, Juliao (GB29), Fengshi (GB31), Weizhong (BL40), and etc. on the left side. After deqi, the electrodes of KWD-808Ⅰimpulse electronic therapeutic device were attached to Jiaji (EX-B2) of L4 and Huantiao (GB30), Fengshi (GB31) and Yanglingquan (GB34) on the left side respectively, at disperse-dense wave, a frequency of 2 Hz/100 Hz, and a current of 2 mA. The needles were retained for 20 min. Acupuncture was operated once every 2 days, 3 interventions a week. When acupuncture was completed in each intervention, moving cupping was followed till the skin turned to be red, along the distribution of the governor vessel, foot-shaoyang gallbladder meridian and foot-taiyang bladder meridian on the left side, of the lumbar region and leg. Moving cupping was delivered once every 2 days, 3 times a week. Once a week, after moving cupping, the cups were retained on the areas with skin stiffness for 8 min to 10 min. One course of the combined therapy of acupuncture and cupping was composed of 6 treatments. After 2 courses of treatment, the skin stiffness on the left buttock region and the lateral side of the lower limb was ameliorated, the swelling on the left lower limb relieved and the walking improved; and the patient could walk continuously for 2 000 m. The combined therapy of acupuncture and cupping provides a new idea for the clinical treatment of stiff skin syndrome. 皮肤僵硬综合征(SSS)是一种极为罕见的非炎性反应性皮肤病,其特征是皮肤硬化和关节活动受限。本文报道了1例SSS患儿,予针刺联合火罐治疗,针刺穴取右侧顶旁1线,左侧L2-L4夹脊穴、环跳、阿是穴、居髎、风市、委中等,针刺得气后,左侧L4夹脊穴和环跳、风市和阳陵泉分别连接一组KWD-808Ⅰ脉冲电疗仪电极,采用疏密波,频率2 Hz/100 Hz,电流2 mA,留针20 min,隔日1次,每周3次;针刺结束后行火罐疗法,沿督脉及左侧足少阳胆经、足太阳膀胱经在腰腿部循行线上走罐,至局部皮肤潮红为度,隔日1次,每周3次,并在皮肤僵硬部位留罐8~10 min,每周1次。针刺联合火罐治疗6次为一疗程,治疗2个疗程后,患儿左侧臀部及下肢外侧皮肤僵硬好转,左侧下肢肿胀缓解,行走明显好转,可连续行走约2 000 m。针刺、拔罐联合疗法,为SSS的临床治疗提供了新的思路。.

#5

Light-chain split luciferase assay implicates pathological NOTCH3 thiol reactivity in inherited cerebral small vessel disease.

The Journal of biological chemistry2025 Mar

Stereotyped mutations in NOTCH3 drive CADASIL, the leading inherited cause of stroke and vascular dementia. The vast majority of these mutations result in alterations in the number of cysteines in the gene product. However, non-cysteine-altering pathogenic mutations have also been identified, making it challenging to discriminate pathogenic from benign NOTCH3 sequence variants. Here, we present a method for quantitative assessment of NOTCH3 mutants, the light chain split luciferase (LSL) assay. In LSL, NOTCH3 mutant fragments, cloned between a split luciferase open reading frame, are transfected into cells, producing secreted luciferase activity that is dependent on the normal structure of NOTCH3. Insertion of point mutants that cause CADASIL results in significantly lower activity. Using a panel of 47 sequences, we determined the sensitivity and specificity of LSL for pathogenic NOTCH3 mutation discrimination to be 100% and 93%. LSL was also modestly successful in differentiating pathogenic proteins responsible for Marfan's disease and Stiff Skin Syndrome. Two additional parameters from the LSL analysis (TCEP rescue of activity and secretion index) were also shown to be useful in characterizing NOTCH3 mutants. We show that the spacing and primary sequence of the light chain module is an important component of the LSL assay, as a single light chain cysteine is critical for pathogenic sequence discrimination. Furthermore, we show that the activity of CADASIL mutant reporters is amplified by the application of cysteine-reactive iodoacetamide, suggesting that LSL may be deployed to screen for novel compounds that suppress pathogenic conformations of NOTCH3.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC59 artigos no totalmostrando 40

2025

Reflections on The Thing's rocklike skin.

Clinics in dermatology
2026

Clinicopathological Challenge: A Progressively Enlarging Hardened Skin Plaque.

International journal of dermatology
2025

[Case of stiff skin syndrome treated with acupuncture and cupping therapy].

Zhongguo zhen jiu = Chinese acupuncture &amp; moxibustion
2025

The clinical phenotypes and therapeutic strategies for stiff skin syndrome: a case series with literature review.

Orphanet journal of rare diseases
2025

Light-chain split luciferase assay implicates pathological NOTCH3 thiol reactivity in inherited cerebral small vessel disease.

The Journal of biological chemistry
2024

New clinical classification of stiff skin syndrome.

Archives of dermatological research
2024

Stiff skin syndrome: long-term follow-up.

Anais brasileiros de dermatologia
2024

Characteristics and onset of presentation of pediatric stiff skin syndrome: A retrospective cohort study of 11 patients in a tertiary care center.

Pediatric dermatology
2023

Stiff skin syndrome: a clinicopathological study of 31 cases.

European journal of dermatology : EJD
2023

Chronic Exertional Compartment Syndrome Requiring Bilateral Fasciotomy: An Atypical Complication of Familial Stiff Skin Syndrome in a Father and Son.

Annals of plastic surgery
2023

Segmental stiff skin syndrome treated with secukinumab.

Pediatric dermatology
2023

Segmental stiff skin syndrome: report of a rare disease.

International journal of dermatology
2022

Classification and rising medication therapy in stiff skin syndrome: A case report and literature review.

Dermatologic therapy
2022

Indurated plaques on the back: distinguishing stiff skin syndrome from scleredema and morphea.

International journal of dermatology
2021

Generalized thickening of the skin and hypertrichosis in a child.

Pediatric dermatology
2021

Segmental stiff skin syndrome (SSS): Clinical case and a brief review.

The Australasian journal of dermatology
2020

[Stiff skin syndrome in a pediatric patient: a therapeutic challenge. Clinical case].

Archivos argentinos de pediatria
2020

Anesthetic implications of a pediatric patient with stiff skin syndrome: A case report.

Paediatric anaesthesia
2020

Pro-Fibrotic Phenotype in a Patient with Segmental Stiff Skin Syndrome via TGF-β Signaling Overactivation.

International journal of molecular sciences
2021

Clinical presentation, sonographic features and treatment options of segmental stiff skin syndrome.

Clinical and experimental dermatology
2020

Sclerodermalike syndromes: Great imitators.

Clinics in dermatology
2020

Acromicric dysplasia with stiff skin syndrome-like severe cutaneous presentation in an 8-year-old boy with a missense FBN1 mutation: Case report and literature review.

Molecular genetics &amp; genomic medicine
2020

Segmental stiff skin syndrome: a novel case with an interleukin-17C mutation successfully treated with secukinumab.

Clinical and experimental dermatology
2019

A disease-associated mutation in fibrillin-1 differentially regulates integrin-mediated cell adhesion.

The Journal of biological chemistry
2019

Review of genodermatoses with characteristic histopathology and potential diagnostic delay.

Journal of cutaneous pathology
2018

Middle-Aged Female Diagnosed With Widespread Stiff Skin Syndrome.

Archives of rheumatology
2019

Ultrasound Morphology of Stiff Skin Syndrome with Clinical and Histological Correlation.

Actas dermo-sifiliograficas
2019

Fibrillin protein pleiotropy: Acromelic dysplasias.

Matrix biology : journal of the International Society for Matrix Biology
2018

Uncommon ulcers in a patient with diabetes.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
2018

Stony Hard Skin During Early Infancy.

The American Journal of dermatopathology
2018

A case of segmental stiff skin syndrome treated with systemic losartan.

Pediatric dermatology
2017

Pathophysiological Mechanisms in Sclerosing Skin Diseases.

Frontiers in medicine
2016

Segmental stiff skin syndrome (SSS): Two additional cases with a positive response to mycophenolate mofetil and physical therapy.

Journal of the American Academy of Dermatology
2016

Initial characterization of stiff skin-like syndrome in West Highland white terriers.

Veterinary dermatology
2016

Segmental stiff skin syndrome (SSS): A distinct clinical entity.

Journal of the American Academy of Dermatology
2016

Skeletal manifestations of Marfan syndrome associated to heterozygous R2726W FBN1 variant: sibling case report and literature review.

BMC musculoskeletal disorders
2016

The ocular phenotype of stiff-skin syndrome.

Eye (London, England)
2015

A 7-year-old with indurated skin and unilateral progressive joint immobility: A case of stiff skin syndrome.

Dermatology online journal
2015

Treatment of Massive Labial and Gingival Hypertrophy in a Patient With Infantile Systemic Hyalinosis-A Case Report.

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
2015

A microfibril assembly assay identifies different mechanisms of dominance underlying Marfan syndrome, stiff skin syndrome and acromelic dysplasias.

Human molecular genetics
Ver todos os 59 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome da pele rígida.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome da pele rígida

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Clinicopathological Challenge: A Progressively Enlarging Hardened Skin Plaque.
    International journal of dermatology· 2026· PMID 40817660mais citado
  2. The clinical phenotypes and therapeutic strategies for stiff skin syndrome: a case series with literature review.
    Orphanet journal of rare diseases· 2025· PMID 40551142mais citado
  3. Reflections on The Thing's rocklike skin.
    Clinics in dermatology· 2025· PMID 41043655mais citado
  4. [Case of stiff skin syndrome treated with acupuncture and cupping therapy].
    Zhongguo zhen jiu = Chinese acupuncture &amp; moxibustion· 2025· PMID 40670176mais citado
  5. Light-chain split luciferase assay implicates pathological NOTCH3 thiol reactivity in inherited cerebral small vessel disease.
    The Journal of biological chemistry· 2025· PMID 39864627mais citado

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:2833(Orphanet)
  2. OMIM OMIM:184900(OMIM)
  3. MONDO:0008492(MONDO)
  4. GARD:5025(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q7616403(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome da pele rígida
Compêndio · Raras BR

Síndrome da pele rígida

ORPHA:2833 · MONDO:0008492
Prevalência
<1 / 1 000 000
Casos
54 casos conhecidos
Herança
Autosomal dominant
CID-10
L98.8 · Outras afecções especificadas da pele e do tecido subcutâneo
CID-11
Início
Childhood, Infancy, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C1861456
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades